Sawyer Jason David 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Aug 18, 2025
Insider Transaction Report
Form 4
Sawyer Jason David
Director
Transactions
- Award
Options to Purchase Common Stock
2025-08-15+25,000→ 25,000 totalExercise: $3.59From: 2025-08-15Exp: 2030-08-15→ Common (25,000 underlying)
Footnotes (1)
- [F1]Effective August 15, 2025, the reporting person was granted stock options to purchase 25,000 shares vesting 50% on the effective date, the remaining 50% vesting 12.5% on December 31, 2025 and on the last day of each subsequent calendar quarter until fully vested, subject to continuous service. The grant was in connection with the reporting person being appointed to the Company's Board of Directors. The exercise price is $3.59 per share.